In a rare stumble for the COVID vaccine star, Moderna will have to restart its CFO search.
Last month, the vaccine maker announced that its new chief financial officer, Jorge Gomez, would officially take the reins on May 9. But just one day after assuming charge, Gomez resigned amid an ongoing internal probe of his former employer.
Dentsply Sirona disclosed the investigation when it notified the SEC that it would be delayed in filing its quarterly financial statements. The dental product's maker said it had launched an internal probe into allegations surrounding the use of incentives to sell products to distributors and whether those incentives and their impact were properly accounted for.
Gomez had served as Dentsply Sirona's executive VP and CFO since August 2019.
Now, Moderna's recently retired finance chief David Meline will return, as the company reopens its search for a new CFO.
Gomez won't walk away empty-handed though. Per Moderna's executive severance plan, he will still receive 12 months' salary, totally $700k.